{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:57:58Z","timestamp":1715993878914},"reference-count":33,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/03007995.2016.1222512","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:13:52Z","timestamp":1470788032000},"page":"1-10","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Cost\u2013utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan"],"prefix":"10.1080","volume":"33","author":[{"given":"Ataru","family":"Igarashi","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Tang","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Cure","sequence":"additional","affiliation":[{"name":"Mapi, Uxbridge, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Guerra","sequence":"additional","affiliation":[{"name":"Mapi, Uxbridge, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile","family":"Mari\u00e9","sequence":"additional","affiliation":[{"name":"Mapi, Uxbridge, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lopresti","sequence":"additional","affiliation":[{"name":"Junicon Japan Inc., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichiro","family":"Tsutani","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,9,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02540.x"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02684.x"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1159\/000327577"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000225126.56483.b3"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00119.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06948.x"},{"issue":"1","key":"CIT0008","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jval.2011.11.012","volume":"15","author":"Liu GG","year":"2012","journal-title":"Value Health"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01182.x"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1750-7"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1159\/000252782"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1159\/000076640"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23691"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12312"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.3310\/hta11110"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.3310\/hta15170"},{"key":"CIT0017","first-page":"625","volume":"62","author":"Fukuda TST","year":"2013","journal-title":"J Natk Inst Publ Health"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12020"},{"key":"CIT0019","first-page":"1020","volume":"2","author":"Yamada I","year":"2015","journal-title":"J Hepat Res"},{"key":"CIT0020","unstructured":"[JSH Guidelines for the Management of Hepatitis C Virus Infection]. 2015. Available at: https:\/\/www.jsh.or.jp\/files\/uploads\/HCV_GL_ver4_Sept01_final.pdf. Last accessed 15 September 2015"},{"key":"CIT0021","unstructured":"EMA. Sovaldi, summary of product characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002798\/WC500160597.pdf. Last accessed 16 September 2015"},{"key":"CIT0022","unstructured":"PegIntron, PMDA Review Report. Pharmaceutical and Medical Devices Agency Feron, PMDA review report. Pharmaceutical and Medical Devices Agency. Available at http:\/\/www.pmda.go.jp\/drugs\/2009\/P200900047\/48022000_22100AMX01812_A100_1.pdf. Last accessed 15 September 2015"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12416"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.215.33"},{"key":"CIT0025","unstructured":"Ishida H, Yotsuyanagi H. [Study of the cost-effectiveness of the standard treatment for chronic hepatitis C]. Ministry of Health Labour and Welfare, 2013 Available at: https:\/\/mhlw-grants.niph.go.jp\/niph\/search\/NIDD00.do?resrchNum=201333004B. Last accessed 16 September 2015"},{"key":"CIT0026","unstructured":"The 21th Life Tables (2010). Ministry of Health, Labour and Welfare, 2010. Available at: http:\/\/www.mhlw.go.jp\/english\/database\/db-hw\/lifetb21th\/dl\/tables.pdf. Last accessed 15 September 2015"},{"key":"CIT0027","volume-title":"[A study in the utility value of hepatitis]","author":"Sugimori H, Ikeda S, et al.","year":"2013"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.3310\/hta10210"},{"key":"CIT0029","unstructured":"Telaprevir for the treatment of genotype 1 chronic hepatitis C \u2013 NICE technology appraisal guidance 252. National Institute for Health and Clinical Excellence, 2012. Available at: https:\/\/www.nice.org.uk\/guidance\/ta252"},{"key":"CIT0030","volume-title":"2015 National Drug Tariff","year":"2015"},{"key":"CIT0031","volume-title":"[Medical expenses for the viral liver diseases]","author":"Ikeda T.","year":"2013"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-11-22"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1481"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2016.1222512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:33:43Z","timestamp":1599348823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2016.1222512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/03007995.2016.1222512"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2016.1222512","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}